for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
EJRR - European Journal of Risk Regulation    [3 followers]  Follow    
  Full-text available via subscription Subscription journal
     ISSN (Print) 1867-299X
     Published by Lexxion Verlagsgesellschaft Homepage  [12 journals]
  • Regulatory Agencies of the European Union as International Actors
    • Abstract: EJRR 04 2013 Regulatory Agencies of the European Union as International Actors 479
      Regulatory Agencies of the European Union
      as International Actors
      Legal Framework, Development over Time and Strategic Motives in
      the Case of the European Food Safety Authority
      Martijn Groenleer* and Simone Gabbi**
      EU agencies, such as the European Food Safety Authority (EFSA), are usually created in an
      environment that is replete with other organizations, not only other European
      PubDate: Tue, 17 Dec 2013 12:32:29 +010
       
  • Book Reviews
    • Abstract: EJRR 04 2013 Book Reviews 587
      Book Reviews
      The Book Reviews section will introduce you to the latest and most interesting books on a wide range
      of topics pertaining to the lawand policy of risk regulation. EJRR Book Reviewswill strive to be present
      in every edition and will accept reviews from all disciplines. For further information on the submission
      of reviews please contact the Book Reviews Editor at david.hornsby@wits.ac.za.
      PubDate: Tue, 17 Dec 2013 12:22:28 +010
       
  • The Seeds of Dispute
    • Abstract: EJRR 04 2013 Case Notes 579
      The Seeds of Dispute:
      Vernon Hugh Bowman v. Monsanto Company et al.
      Emanuela Gambini*
      In May 2013, the U.S. Supreme Court decided in Vernon Hugh Bowman v. Monsanto Company
      et al. in favor of Monsanto Company, affirming the judgment of the U.S. Court of Appeals
      for the Federal Circuit and holding that patent exhaustion does not permit a farmer
      to reproduce patented seeds through planting and harvesting without the patent holder’s
      PubDate: Tue, 17 Dec 2013 12:20:48 +010
       
  • Judgment of the General Court of the EU on Access to Information under
           Substance Law
    • Abstract: EJRR 04 2013 Case Notes 565
      Judgment of the General Court of the EU on Access
      to Information under Substance Law
      Case T-545/11, Judgment of 08 October 2013.
      Horst von Holleben*
      On 08 October 2013, the General Court of the European Union (hereinafter General Court)
      delivered a judgment based on the Aarhus Regulation 1367/2006 on the access to information
      on substances under plant protection law,which attracted considerable attention among
      experts with confl
      PubDate: Tue, 17 Dec 2013 12:19:04 +010
       
  • On the Remit of the Fairchild Principle and the ‘Doubles the
           Risk’ Test for Causation
    • Abstract: EJRR 04 2013 Case Notes 559
      On the Remit of the Fairchild Principle
      and the ‘Doubles the Risk’ Test for Causation
      Sienkiewicz v Greif [2011] UKSC 10
      Claire McIvor*
      I. The Facts
      The claim in Sienkiewicz concerned liability in negligence
      for occupational exposure to asbestos. The
      victim in question had developed, and subsequently
      died from,mesothelioma and her estate sought to establish
      that the disease had been caused by her former
      employ
      PubDate: Tue, 17 Dec 2013 12:17:33 +010
       
  • Orphacol: A Judgment with More Questions than Answers
    • Abstract: EJRR 04 2013 Case Notes 551
      Case Notes
      Orphacol: A Judgment with More Questions than Answers
      Case T-301/12: Laboratoires CTRS v. European Commission
      Cándido García Molyneux*
      I. Introduction
      This summer, the General Court ended three years
      of quarrelling among the French pharmaceutical
      company Laboratoires CTRS (“CTRS”), the European
      Medicines Agency (“EMA”), the European Commission
      and Member States by deciding the Orphacol
      case.1
      PubDate: Tue, 17 Dec 2013 12:15:04 +010
       
  • Trade, Investment and Risk: Latest Procedural Developments Related to the
           WTO Dispute US – ...
    • Abstract: 548 Reports EJRR 04 2013
      Latest Procedural Developments Related to the WTO Dispute
      US – Clove Cigarettes
      Eugenia Costanza Laurenza*
      I. Introduction
      On 13 August 2013, the Government of Indonesia requested
      a special meeting of the WTO Dispute Settlement
      Body (hereinafter, DSB) in order to obtain
      authorisation to suspend concessions or other obligations
      (i.e., to ‘retaliate’) against the United States
      (hereinafter, theUS). This request stems
      PubDate: Tue, 17 Dec 2013 12:12:50 +010
       
  • Trade, Investment and Risk: International Economic Law Meets Lifestyle
           Risks: What Role for ...
    • Abstract: 542 Reports EJRR 04 2013
      Trade, Investment and Risk
      This section highlights the interface between international trade and investment law and minicipal
      and international risk regulation. It is meant to cover cases and other legal developments in WTO
      law (SPS, TBT and TRIPS Agreements and the general exceptions in both GATT 1994 and GATS), bilateral
      investment treaty arbitration and other free trade agreements such as NAFTA. Pertinent developments
      in international sta
      PubDate: Tue, 17 Dec 2013 12:11:26 +010
       
  • Regulatory Impact Assessment: A New Approach to ex post Evaluation in the
           EU: The Cumulative ...
    • Abstract: EJRR 04 2013 Reports 539
      Regulatory Impact Assessment
      This section regularly examines Regulatory Impact Assessment (IA) at three levels: the EU, theMember
      States and internationally. Contributions aim to cover aspects such as the interface between IA
      and risk analysis, looking atmethodologies as well as legal and political science-related issues. Contributions
      are meant to report and critically assess recent developments in the field, develop strategic
      thinking, and
      PubDate: Tue, 17 Dec 2013 12:09:51 +010
       
  • Pharmaceuticals: Simple, Safe And Transparent(?): Preliminary
           Reflections on the Proposal for a ...
    • Abstract: 534 Reports EJRR 04 2013
      Pharmaceuticals
      This section updates readers on the latest developments in pharmaceutical law, giving information
      on legislation and case law on variousmatters (such as clinical and pre-clinical trials, drug approval
      and marketing authorisation, the role of regulatory agencies) and providing analysis on how and
      to what extent they might affect health and security of the individual as well as in industry.
      Simple, Safe And Transparent(?): Prel
      PubDate: Tue, 17 Dec 2013 12:08:31 +010
       
  • Lifestyle Risks: DSM-5: What’s New?
    • Abstract: EJRR 04 2013 Reports 531
      Lifestyle Risks
      This section discusses the regulation of “lifestyle risks”, a term that can apply to both substances
      and behaviours. Lifestyle risks take place along the line of “abstinence – consumption – abuse – addiction”.
      This can concern substances such as food, alcohol or drugs, as well as behaviours such as
      gambling or sports. The section also addresses the question of the appropriate point of equilibrium
      between free ch
      PubDate: Tue, 17 Dec 2013 12:07:15 +010
       
  • Food: Hungary and Belgium Intend Limiting Trans Fats in Foodstuffs, as
           Done by other EU Member ...
    • Abstract: EJRR 04 2013 Reports 527
      Food
      This section aims at updating readers on the latest developments of risk-related aspects of food law
      at the EU level, giving information on legislation and case law on various matters, such as food safety,
      new diseases, animal health and welfare and food labelling.
      Hungary and Belgium Intend Limiting Trans Fats in Foodstuffs,
      as Done by other EU Member States
      Ignacio Carreño*
      I. Introduction
      On 6 July 2013,Hungary notifi
      PubDate: Tue, 17 Dec 2013 12:05:47 +010
       
  • Biotechnology: FDA is ready to Authorize GM Salmons but is the Market
           ready for them?
    • Abstract: EJRR 04 2013 Reports 521
      Reports
      This part of the EJRR hosts reports in which our correspondents keep readers up to date on the most
      recent developments in different areas of risk regulation. Our aim is to fuel the debate and trigger future
      research on cutting-edge risk subjects. The Reports are organised under different policy sections.
      Further sections will be added at regular intervals. If you are interested in contributing to any of the
      existing sections, please
      PubDate: Tue, 17 Dec 2013 11:59:03 +010
       
  • Minors and Gambling Regulation
    • Abstract: EJRR 04 2013 Minors and Gambling Regulation 509
      Minors and Gambling Regulation
      Malgorzata (Margaret) Carran*
      Early initiation of gambling has been argued to be closely correlated with placing players
      at higher risk of developing problem gambling behaviour in the future. The vast majority of
      jurisdictions, including Great Britain, attempts to eliminate minors’ access to gambling by
      making it illegal and by requiring gambling providers to adopt strict age-verificati
      PubDate: Tue, 17 Dec 2013 11:57:08 +010
       
  • Trade, the Precautionary Principle, and Post-Modern Regulatory Process
    • Abstract: EJRR 04 2013 Trade, the Precautionary Principle, and Post-Modern Regulatory Process 493
      Trade, the Precautionary Principle,
      and Post-Modern Regulatory Process
      Regulatory Convergence in the Transatlantic Trade and Investment
      Partnership*
      Lucas Bergkamp and Lawrence Kogan**
      I. Introduction
      The Transatlantic Trade and Investment Partnership
      (“TTIP”) has been hailed as an opportunity for the
      world’s two largest consumer markets to expand inter-
      PubDate: Tue, 17 Dec 2013 11:54:04 +010
       
  • What is the Best Way to Supervise the Quality of Medical Devices?
           Searching for a Balance ...
    • Abstract: EJRR 04 2013 Symposium on the EU’s New Medical Devices Regulatory Framework 465
      What is the Best Way to Supervise the Quality
      of Medical Devices? Searching for a Balance
      Between ex-ante and ex-post Regulation
      Shanta Marjolein Singh*
      This article discusses the legal remedies available for Competent Authorities, patients and
      healthcare professionals to prevent harmful incidents involving medical devices. It outlines
      a theoretical framework for ex-ante and ex-po
      PubDate: Tue, 17 Dec 2013 11:52:17 +010
       
  • US Perspectives on the EU Medical Device Approval System, and Lessons
           Learned from the United States
    • Abstract: EJRR 04 2013 Symposium on the EU’s New Medical Devices Regulatory Framework 443
      US Perspectives on the EU Medical Device
      Approval System, and Lessons Learned from
      the United States
      Christa Altenstetter*
      The literature on the regulation of drugs at the FDA and the European Union is substantial,
      yet little research has provided comparative analyses and robust empirical data on the regulation
      of medical devices in the United States and the European Union. As med
      PubDate: Tue, 17 Dec 2013 11:50:55 +010
       
  • Are We Wasting a Good Crisis? The Revision of the EU Medical Devices
           Directives and the Impact ...
    • Abstract: EJRR 04 2013 Symposium on the EU’s New Medical Devices Regulatory Framework 437
      Are We Wasting a Good Crisis? The Revision
      of the EU Medical Devices Directives and the
      Impact of Health Data Rules
      Alex Denoon* and Erik Vollebregt**
      I. Introduction
      The three Directives concerningmedical devices1 are
      currently under revision and a long process that started
      with a consultation in 2008 seems to be nearing
      its conclusion with two Regulation proposals in t
      PubDate: Tue, 17 Dec 2013 11:49:27 +010
       
  • Revision of the Regulatory Framework for Medical Devices in the EU: The
           Legal Challenges
    • Abstract: EJRR 04 2013 Symposium on the EU’s New Medical Devices Regulatory Framework 429
      Revision of the Regulatory Framework for
      Medical Devices in the European Union:
      The Legal Challenges
      Leigh Hancher and Maria Eva Földes*
      I. Introduction
      This special edition of the European Journal of Risk
      Regulation deals with a highly topical, complex and
      controversial subject matter – the reform of the regulation
      of medical devices in the European Union.
      At fi
      PubDate: Tue, 17 Dec 2013 11:48:04 +010
       
  • Editorial
    • Abstract: The European Journal of Risk Regulation closes the year by hosting a special issue devoted
      to the ongoing reformof the regulation ofmedical devices in the EuropeanUnion.
      It builds upon an international conference titled ‘Revising Medical Devices Regulation
      – The Legal Challenges’, organized at Tilburg University, in co-operation with the
      EJRR. Both the event and this special issue were led by Professor Leigh Hancher, assisted
      by Maria Eva Földes, from Tilburg Univ
      PubDate: Tue, 17 Dec 2013 11:45:52 +010
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014